Skip to main content
Fig. 5 | Journal of Translational Medicine

Fig. 5

From: Gastric cancer vaccines synthesized using a TLR7 agonist and their synergistic antitumor effects with 5-fluorouracil

Fig. 5

Additive effects of 5-FU and T7 − MB on tumor inhibition using the prophylactic schedule (n ≥ 5 mice/group). a Tumor growth curves displaying tumor volumes, where the dimensions were measured twice a week until day 21 (two-way ANOVA). b Tumor weights were determined at the time of sacrifice on day 21, where the PBS control (100%) was 1.06 ± 0.08 g. c Survival curves indicating that post-treatment effects were exerted on tumor-bearing mice for more than 70 days (log-rank test). The data represent the mean ± SE; *P < 0.05 and ***P < 0.001 compared to the PBS control group

Back to article page